PSDV: pSivida Corp. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

pSivida Corp.

NASDAQ:PSDV

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$1.15
Loss Chance
55.1%
2.25JITTA SCORE
39.21%Over Jitta Line
Jitta Ranking
Life Sciences Tools and Services
0 / 38
Healthcare
0 / 1
United States
?
4,134 / 4,151
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Agilent Technologies
NYSE:A
7.24
$114.79
177.56%
Bio-Rad Laboratories
NYSE:BIO
4.35
$286.74
87.69%
Bruker Corporation
NASDAQ:BRKR
3.52
$44.98
106.67%
Cambrex Corporation
NYSE:CBM
5.18
$59.99
86.52%
Enzo Biochem
NYSE:ENZ
1.77
$0.69
100.00%
Jitta Factors
Growth Opportunity (46)
Recent Business Performance (10)
Financial Strength (10)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Revenue and EarningEarning loss detected in 2017
Operating MarginDeclined
Recent Business PerformanceEarning decline 14.21% in the last year
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
2.25
39.21%
3.89
> 1,000%
3.20
100.00%
Life Sciences Tools and Services
7.24
177.56%
4.35
87.69%
3.52
106.67%
COMPANY DESCRIPTION
pSivida Corp. develops sustained-release drug-delivery products for the treatment of chronic eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior segment uveitis. The company is also developing Durasert, an injectable, sustained-release micro-insert, which is in Phase III clinical trials for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. It is also developing Durasert, which is in pre-clinical trials for the treatment of posterior segment uveitis; steroid implant for severe knee osteoarthritis; and TKI Insert, an injectable, bioerodible, sustained-release Durasert insert delivering a tyrosine kinase inhibitor for treatment of wet age-related macular degeneration. The company has strategic collaborations with Alimera Sciences, Inc.; Pfizer, Inc.; Bausch & Lomb Incorporated; Enigma Therapeutics Limited; and Nicox S.A. pSivida Corp. was founded in 1987 and is based in Watertown, Massachusetts.
www.psivida.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.